Literature DB >> 3194848

Poorly differentiated ("insular") carcinoma of the thyroid gland: an aggressive subset of differentiated thyroid neoplasms.

S D Flynn1, B H Forman, A F Stewart, B K Kinder.   

Abstract

Four patients with a histologically distinctive thyroid carcinoma--which recently has been referred to as poorly differentiated ("insular") carcinoma--are reported. This study confirms the previous conclusions that patients with this neoplasm often experience an aggressive clinical course, with focal recurrences and distant metastases common, which results in death in the majority of patients. Such aggressive behavior may occur even when the insular component accounts for only a small percentage of an otherwise well-differentiated carcinoma, as seen in one of our patients. After subtotal or total thyroidectomy, three of the four patients have experienced local recurrence (1) and metastases to lung (3), mediastinum (1), and bone (1). All three of these patients died within 2 years of the diagnosis of insular carcinoma. The remaining patient is alive without evidence of disease 1 year after total thyroidectomy. Histologically, this neoplasm is characterized by well-defined nests (insulae) that are composed of relatively small, uniform cells and sometimes associated with small, thyroglobulin-containing follicles. Tumor necrosis is often present. Insular carcinoma may comprise the entire neoplasm (2 patients) or be associated with well-differentiated follicular (1 patient) or papillary (1 patient) carcinoma. The rapid and often fatal course associated with insular carcinoma warrants aggressive treatment at the time of initial diagnosis, including total thyroidectomy and node dissection (if involved), as well as possible iodine-131, external beam irradiation and chemotherapy.

Entities:  

Mesh:

Year:  1988        PMID: 3194848

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  8 in total

1.  Therapeutic strategy for differentiated thyroid carcinoma in Japan based on a newly established guideline managed by Japanese Society of Thyroid Surgeons and Japanese Association of Endocrine Surgeons.

Authors:  Hiroshi Takami; Yasuhiro Ito; Takahiro Okamoto; Akira Yoshida
Journal:  World J Surg       Date:  2011-01       Impact factor: 3.352

2.  Insular carcinomas of the thyroid exhibit poor prognosis and long-term survival in comparison to follicular and papillary T4 carcinomas.

Authors:  Ayman Agha; Gabriel Glockzin; Matthias Woenckhaus; Wolfgang Dietmaier; Igors Iesalnieks; Hans J Schlitt
Journal:  Langenbecks Arch Surg       Date:  2007-01-10       Impact factor: 3.445

3.  Insular and anaplastic carcinoma of the thyroid: a 45-year comparative study at a single institution and a review of the significance of p53 and p21.

Authors:  K Y Lam; C Y Lo; K W Chan; K Y Wan
Journal:  Ann Surg       Date:  2000-03       Impact factor: 12.969

4.  Prognostic Impact of the Turin Criteria in Poorly Differentiated Thyroid Carcinoma.

Authors:  Junko Akaishi; Tetsuo Kondo; Kiminori Sugino; Yuna Ogimi; Chie Masaki; Kiyomi Y Hames; Tomonori Yabuta; Chisato Tomoda; Akifumi Suzuki; Kenichi Matsuzu; Takashi Uruno; Keiko Ohkuwa; Wataru Kitagawa; Mitsuji Nagahama; Ryohei Katoh; Koichi Ito
Journal:  World J Surg       Date:  2019-09       Impact factor: 3.352

5.  Insular thyroid carcinoma in a young Moroccan man: Case report and review of the literature.

Authors:  Wahiba Abdellaoui; Imane Assarrar; Salma Benyakhlef; Abir Tahri; Najoua Messaoudi; Anass Haloui; Siham Rouf; Amal Bennani; Hanane Latrech
Journal:  Ann Med Surg (Lond)       Date:  2022-04-06

6.  Insular carcinoma: infrequent subtype of thyroid cancer with aggressive clinical course.

Authors:  Tzu-Chieh Chao; Jen-Der Lin; Miin-Fu Chen
Journal:  World J Surg       Date:  2004-03-04       Impact factor: 3.352

7.  Insular thyroid carcinoma in a Filipino woman.

Authors:  Mark Anthony S Sandoval; Elizabeth Paz-Pacheco
Journal:  BMJ Case Rep       Date:  2010-11-18

8.  T lymphocytes, CD68-positive cells and vascularisation in thyroid carcinomas.

Authors:  G Herrmann; P M Schumm-Draeger; C Müller; E Atai; B Wenzel; T Fabian; K H Usadel; K Hübner
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.